Entheon Biomedical Corp Stock Cash Flow From Operations
| ENTBF Stock | USD 0.12 0.03 33.33% |
Entheon Biomedical Corp fundamentals help investors to digest information that contributes to Entheon Biomedical's financial success or failures. It also enables traders to predict the movement of Entheon OTC Stock. The fundamental analysis module provides a way to measure Entheon Biomedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Entheon Biomedical otc stock.
Entheon |
Entheon Biomedical Corp OTC Stock Cash Flow From Operations Analysis
Entheon Biomedical's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Entheon Biomedical Cash Flow From Operations | (5.62 M) |
Most of Entheon Biomedical's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Entheon Biomedical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Entheon Biomedical Corp has (5.62 Million) in Cash Flow From Operations. This is 101.06% lower than that of the Healthcare sector and 108.98% lower than that of the Biotechnology industry. The cash flow from operations for all United States stocks is 100.58% higher than that of the company.
Entheon Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Entheon Biomedical's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Entheon Biomedical could also be used in its relative valuation, which is a method of valuing Entheon Biomedical by comparing valuation metrics of similar companies.Entheon Biomedical is currently under evaluation in cash flow from operations category among its peers.
Entheon Fundamentals
| Return On Equity | -0.55 | |||
| Return On Asset | -0.46 | |||
| Operating Margin | (60.27) % | |||
| Current Valuation | 1.12 M | |||
| Shares Outstanding | 59.09 M | |||
| Shares Owned By Insiders | 8.63 % | |||
| Price To Book | 0.22 X | |||
| Price To Sales | 9.60 X | |||
| Revenue | 21.67 K | |||
| Gross Profit | 9.13 K | |||
| EBITDA | (8.62 M) | |||
| Net Income | (8.89 M) | |||
| Cash And Equivalents | 467.58 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 300 K | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 0.97 X | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (5.62 M) | |||
| Earnings Per Share | (0.11) X | |||
| Beta | 1.89 | |||
| Market Capitalization | 1.3 M | |||
| Total Asset | 9.98 M | |||
| Z Score | 2.4 | |||
| Net Asset | 9.98 M |
About Entheon Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Entheon Biomedical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Entheon Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Entheon Biomedical Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Entheon OTC Stock
Entheon Biomedical financial ratios help investors to determine whether Entheon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entheon with respect to the benefits of owning Entheon Biomedical security.